Document is current
Any future updates will be listed below
-
Authors
Assouline, Benjamin
Kahn, Rachel
Hodali, Lutfi
Condiotti, Reba
Engel, Yarden
Elyada, Ela
Mordechai-Heyn, Tzlil
Pitarresi, Jason R.
Atias, Dikla https://orcid.org/0000-0003-3362-025X
Steinberg, Eliana
Bidany-Mizrahi, Tirza
Forkosh, Esther
Katz, Lior H.
Benny, Ofra https://orcid.org/0000-0002-2468-5978
Golan, Talia
Hofree, Matan
Stewart, Sheila A. https://orcid.org/0000-0002-2260-9576
Atlan, Karine A.
Zamir, Gideon
Stanger, Ben Z. https://orcid.org/0000-0003-0410-4037
Berger, Michael https://orcid.org/0000-0002-3469-0076
Ben-Porath, Ittai https://orcid.org/0000-0001-7815-1165
- License Information
-
More Information
Article History
Received: 6 August 2023
Accepted: 5 July 2024
First Online: 22 July 2024
Competing interests
: B.Z.S. receives sponsored research support from Boehringer-Ingelheim and Revolution Medicines and holds equity in iTeos Therapeutics. T.G. Receives research support from Astra Zeneca, Abbvie honoraria, consultation fees from Abbvie and MSD Merck, royalties and consultant fees from Curesponse, and speaker fees from Abbvie and ClearNote Health. The remaining authors declare no competing interests.
